# Tofacitnib for the Treatment of Alopecia Areata and Variants

> **NCT02197455** · PHASE2 · COMPLETED · sponsor: **Yale University** · enrollment: 30 (actual)

## Conditions studied

- Alopecia Areata (AA)
- Alopecia Totalis (AT)
- Alopecia Universalis (AU)

## Interventions

- **DRUG:** Tofacitinib Administration

## Key facts

- **NCT ID:** NCT02197455
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2017-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02197455

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02197455, "Tofacitnib for the Treatment of Alopecia Areata and Variants". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02197455. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*